Omlonti Side Effects

Generic name: omidenepag isopropyl ophthalmic

Medically reviewed by Drugs.com. Last updated on Nov 14, 2024.

Note: This document provides detailed information about Omlonti.

Applies to omidenepag isopropyl ophthalmic: ophthalmic solution Side Effects associated with omidenepag isopropyl ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Omlonti.

Applies to omidenepag isopropyl ophthalmic: ophthalmic solution.

Side effects include:

The most common adverse reactions with incidence ≥1% are conjunctival hyperemia, photophobia, blurred vision, dry eye, instillation site pain, eye pain, ocular hyperemia, punctate keratitis, headache, eye irritation, and visual impairment.

For healthcare professionals

Applies to omidenepag isopropyl ophthalmic: ophthalmic solution.

General adverse events

The most common adverse reactions reported were conjunctival hyperemia, photophobia, blurred vision, dry eye, instillation site pain, eye pain, ocular hyperemia, punctate keratitis, headache, eye irritation, and visual impairment.^[Ref]

Ocular

• Frequency not reported: Eyelash changes, iris pigmentation, vellus hair, ocular Inflammation, macular edema, cystoid macular edema^[Ref]

Pigmentation of the iris is likely to be permanent after discontinuation.

Eyelash changes include increased length, thickness, and the number of lashes or hairs. These changes are usually reversible upon discontinuation of treatment.^[Ref]

Dermatologic

• Frequency not reported: Pigmentation^[Ref]

Reversible pigmentation of the periorbital tissue occurred with the use of this drug.^[Ref]

Further information

Omlonti side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer